Unique Ingredient Identifier 451W47IQ8X is listed as a ingredient substance
| RN | 7647-14-5 |
| EC | 231-598-3 |
| NCIT | C29974 |
| RXCUI | 9863 |
| INN ID | 4155 |
| MF | Cl.Na |
| INCHI KEY | FAPWRFPIFSIZLT-UHFFFAOYSA-M |
| SMILES | [Na+].[Cl-] |
UNII 451W47IQ8X SODIUM CHLORIDE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| IV(INFUSION) | INJECTION | 0.59 % |
| OPHTHALMIC | SOLUTION | 0.81 % |
| INTRAVENOUS | INJECTION | 0.9 % |
| INTRAVENOUS | SOLUTION | 0.9 % |
| AN,CNBLK INTRATHECAL | INJECTION | 0.8 % |
| AN,INFILTRATION | INJECTABLE | NA |
| AN,INFILTRATION | INJECTION | 0.9 % |
| AN,INFILTRATION | SOLUTION, INJECTION | 0.65 % |
| AN,SYMPATHETIC NBLK | INJECTION | 0.3 % |
| AURICULAR (OTIC) | SOLUTION | 9 % |
| AURICULAR (OTIC) | SUSPENSION | 0.86 % |
| AURICULAR (OTIC) | SUSPENSION, LIQUID | 0.9 % |
| CAUDAL BLOCK | INJECTABLE | NA |
| CAUDAL BLOCK | INJECTION | 0.9 % |
| DENTAL | INJECTABLE | 0.3 % |
| DENTAL | INJECTION | 0.6 % |
| EPIDURAL | INJECTION | 24 % |
| EPIDURAL | INJECTION | 8.6 mg/1mL |
| EPIDURAL | INJECTION, SOLUTION | 8 mg/1mL |
| EPIDURAL | LIQUID, WATER, STERILE, FOR INJECTION | 0.8 % |
| EPIDURAL | SOLUTION | 0.9 % |
| EPIDURAL | SOLUTION, INJECTION | 0.9 % |
| EPIDURAL, INFILTRATION, NERVE BLOCK | INJECTION | 8.6 MG/ML |
| EXTRACORPOREAL | INJECTION | 0.9 % |
| EXTRACORPOREAL | SOLUTION | 0.8 % |
| IM - IV | INJECTABLE | 0.9 % |
| IM - IV | INJECTION | 14 % |
| IM - IV | INJECTION | 4.9 mg/mL |
| IM - IV | LIQUID, WATER, STERILE, FOR INJECTION | 0.8 % |
| IM - IV | POWDER, FOR INJECTION SOLUTION | 9 % |
| IM - IV | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 18 % |
| IM - IV | SOLUTION | 0.9 % |
| IM - IV | SOLUTION, INJECTION | 0.9 % |
| IM - IV - SC | INJECTION | 0.9 % |
| IM - IV - SC | SOLUTION, INJECTION | NA |
| IM - SC | INJECTION | 0.9 % |
| INFILTRATION | INJECTION | 8.6 mg/1mL |
| INFILTRATION | INJECTION | 0.86 % |
| INFILTRATION | INJECTION, LIPOSOMAL | 0.54 % |
| INFILTRATION | INJECTION, SOLUTION | 7 MG/1ML |
| INFILTRATION | SOLUTION, INJECTION | 0.85 % |
| INHALATION | INHALANT | NA |
| INHALATION | INHALANT SOLUTION DOSAGE FORM | 11.25 mg/5mL |
| INHALATION | SOLUTION | 27 mg/3 mL |
| INHALATION | SOLUTION | 9 mg/3mL |
| INHALATION | SOLUTION | 8 MG/1ML |
| INHALATION | SOLUTION | 0.9 %W/V |
| INHALATION | SOLUTION, FOR INHALATION | 1.13 % |
| INHALATION | SUSPENSION | 17.2 mg/2mL |
| INHALATION | SUSPENSION, FOR INHALATION | 0.85 % |
| INJECTION | INJECTION | 8.5 mg/1mL |
| INJECTION | INJECTION, SOLUTION | 7 mg/1mL |
| INTRA-ARTERIAL | INJECTABLE | 0.49 % |
| INTRA-ARTERIAL | INJECTION | 19.6 % |
| INTRA-ARTERIAL | INJECTION | 4.9 mg/mL |
| INTRA-ARTERIAL | POWDER, FOR INJECTION SOLUTION | 0.14 % |
| INTRA-ARTERIAL | SOLUTION | 0.9 % |
| INTRA-ARTERIAL | SOLUTION, INJECTION | 0.05 % |
| INTRA-ARTERIAL | SUSPENSION, INJECTION | 1.5 mg/1mL |
| INTRA-ARTICULAR | INJECTABLE | 0.67 % |
| INTRA-ARTICULAR | INJECTION | 6.5 MG/1ML |
| INTRA-ARTICULAR | INJECTION | 0.9 % |
| INTRA-ARTICULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 45 MG |
| INTRA-ARTICULAR | INJECTION, SUSTAINED ACTION | NA |
| INTRA-ARTICULAR | SUSPENSION | 0.48 % |
| INTRABURSAL | INJECTION | 0.9 % |
| INTRACARDIAC | INJECTION | 35 mg/5mL |
| INTRACARDIAC | INJECTION | 0.7 % |
| INTRACARDIAC | SOLUTION, INJECTION | NA |
| INTRACAUDAL | INJECTION | 0.86 % |
| INTRACAUDAL | INJECTION, SOLUTION | 7 MG/1ML |
| INTRACAVITARY | INJECTION | 0.82 % |
| INTRACAVITARY | POWDER, FOR INJECTION SOLUTION | NA |
| INTRADERMAL | INJECTION | 0.7 % |
| INTRADERMAL | INJECTION, SUSTAINED ACTION | NA |
| INTRALESIONAL | INJECTABLE | 0.87 % |
| INTRALESIONAL | INJECTION | 0.85 % |
| INTRALESIONAL | INJECTION, SUSTAINED ACTION | 0.9 % |
| INTRALESIONAL | SUSPENSION, INJECTION | 1.5 mg/1mL |
| INTRALESIONAL | SUSPENSION, INJECTION | 0.22 % |
| INTRAMUSCULAR | INJECTABLE | 3.3 mg/1mL |
| INTRAMUSCULAR | INJECTABLE | 0.87 %W/V |
| INTRAMUSCULAR | INJECTION | 9 MG/1ML |
| INTRAMUSCULAR | INJECTION | 0.86 %W/V |
| INTRAMUSCULAR | INJECTION, SOLUTION | 4.6 MG/1ML |
| INTRAMUSCULAR | INJECTION, SOLUTION | 0.9 %W/V |
| INTRAMUSCULAR | INJECTION, SOLUTION | 0.8 % |
| INTRAMUSCULAR | INJECTION, SUSPENSION | 0.87 % |
| INTRAMUSCULAR | INJECTION, SUSPENSION, EXTENDED RELEASE | 1.96 % |
| INTRAMUSCULAR | INJECTION, SUSTAINED ACTION | 0.9 %W/V |
| INTRAMUSCULAR | LIQUID | 0.67 %W/V |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION | 22.6 % |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH | 0.24 % |
| INTRAMUSCULAR | SOLUTION | 9 mg/1mL |
| INTRAMUSCULAR | SOLUTION, INJECTION | 0.9 %W/V |
| INTRAMUSCULAR | SUSPENSION | 0.9 % |
| INTRAMUSCULAR | SUSPENSION, INJECTION | 8.68 MG/1ML |
| INTRAMUSCULAR | SUSPENSION, INJECTION | 0.87 %W/V |
| INTRAOCULAR | SOLUTION | 9 mg/1mL |
| INTRAOCULAR | SOLUTION | 0.7 % |
| INTRAPERITONEAL | POWDER, FOR INJECTION SOLUTION | 22.6 % |
| INTRAPERITONEAL | SOLUTION | 0.54 % |
| INTRAPLEURAL | POWDER, FOR INJECTION SOLUTION | 22.6 % |
| INTRASYNOVIAL | INJECTABLE | 0.87 % |
| INTRASYNOVIAL | INJECTION | 0.9 % |
| INTRASYNOVIAL | INJECTION, SUSTAINED ACTION | 0.9 % |
| INTRASYNOVIAL | SUSPENSION, INJECTION | 0.22 % |
| INTRA-SYNOVIAL | SUSPENSION, INJECTION | 1.5 mg/1mL |
| INTRATHECAL | INJECTABLE | 0.9 % |
| INTRATHECAL | INJECTION | 19.6 % |
| INTRATHECAL | INJECTION | 9 MG/ML |
| INTRATHECAL | INJECTION, SOLUTION | 8 mg/1mL |
| INTRATHECAL | INJECTION, SUSPENSION, LIPOSOMAL | 9 % |
| INTRATHECAL | POWDER, FOR INJECTION SOLUTION | 0.14 % |
| INTRATHECAL | SOLUTION, INJECTION | 7.2 MG/1ML |
| INTRATHECAL | SOLUTION, INJECTION | 0.9 % |
| INTRATRACHEAL | INJECTION | 1.2 % |
| INTRATRACHEAL | POWDER, FOR SUSPENSION | 4.68 % |
| INTRATRACHEAL | SUSPENSION | 0.76 % |
| INTRATUMOR | INJECTABLE | NA |
| INTRATUMOR | INJECTION | 1.2 % |
| INTRATUMOR | POWDER, FOR INJECTION SOLUTION | NA |
| INTRATYMPANIC | SUSPENSION | 0.43 %W/W |
| INTRAVASCULAR | INJECTION | 8.6 mg/1mL |
| INTRAVASCULAR | INJECTION | 0.19 % |
| INTRAVASCULAR | SOLUTION | NA |
| INTRAVENOUS | INJECTABLE | 90 % |
| INTRAVENOUS | INJECTABLE | 9 MG/1ML |
| INTRAVENOUS | INJECTION | 18 MG/1ML |
| INTRAVENOUS | INJECTION | 9.14 % |
| INTRAVENOUS | INJECTION | 9 MG/ML |
| INTRAVENOUS | INJECTION | 0.9 %W/V |
| INTRAVENOUS | INJECTION, EMULSION | 6.2 MG/ML |
| INTRAVENOUS | INJECTION, SOLUTION | 9 MG/1ML |
| INTRAVENOUS | INJECTION, SOLUTION | 0.9 % |
| INTRAVENOUS | LIQUID | 0.9 % |
| INTRAVENOUS | LIQUID, WATER, STERILE, FOR INJECTION | 0.9 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 48.7 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 13.7 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 4.5 MG/1VIAL |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH | 3.15 % |
| INTRAVENOUS | SOLUTION | 0.9 % |
| INTRAVENOUS | SOLUTION, INJECTION | 9 MG/ML |
| INTRAVENOUS | SOLUTION, INJECTION | 8.9 % |
| INTRAVENOUS | SOLUTION, INJECTION | 0.8 % |
| INTRAVENOUS | SOLUTION, LIQUID | 801.1 uL/1mL |
| INTRAVENOUS BOLUS | INJECTABLE | 0.9 % |
| INTRAVENOUS BOLUS | SOLUTION, INJECTION | 0.9 % |
| INTRAVENOUS INFUSION | INJECTABLE | 9 MG/1ML |
| INTRAVENOUS INFUSION | INJECTION | 4.8 MG/1ML |
| INTRAVENOUS INFUSION | INJECTION, SOLUTION | 9 MG/1ML |
| INTRAVENOUS INFUSION | INJECTION, SOLUTION | 0.9 % |
| INTRAVESICAL | SOLUTION, INJECTION | 35.1 % |
| INTRAVITREAL | INJECTABLE | 10 % |
| INTRAVITREAL | INJECTION | 0.77 % |
| INTRAVITREAL | SUSPENSION, INJECTION | 0.55 % |
| IONTOPHORESIS | DRUG DELIVERY SYSTEM | 0.6 MG |
| IONTOPHORESIS | PATCH, CONTROLLED RELEASE | 3.1 MG |
| IONTOPHORESIS | SOLUTION | 0.6 % |
| IV - SC | INJECTION | 8.6 MG/1ML |
| IV - SC | INJECTION | 1.8 % |
| IV - SC | LIQUID | 0.7 % |
| IV - SC | POWDER, FOR INJECTION SOLUTION | 0.68 % |
| IV - SC | SOLUTION, INJECTION | 0.9 % |
| IV (INFUSION) | SOLUTION | 9 MG/1ML |
| IV(INFUSION) | INJECTABLE | 0.9 % |
| IV(INFUSION) | INJECTION | 45 % |
| IV(INFUSION) | INJECTION | 8.5 mg/1mL |
| IV(INFUSION) | LIQUID | 0.9 % |
| IV(INFUSION) | LIQUID, WATER, STERILE, FOR INJECTION | 0.8 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 45 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH | 3.15 % |
| IV(INFUSION) | SOLUTION, INJECTION | 9 MG/1ML |
| IV(INFUSION) | SOLUTION, INJECTION | 0.9 % |
| IV(INFUSION) | SUSPENSION, INJECTION | 0.9 % |
| NASAL | SOLUTION | 0.9 % |
| NASAL | SOLUTION, FOR INHALATION | 1.13 % |
| NASAL | SOLUTION, SPRAY | 0.68 % |
| NASAL | SOLUTION, SPRAY, METERED, PUMP | 0.093 % |
| NASAL | SPRAY | 7.5 MG/1ML |
| NASAL | SPRAY | 0.7 % |
| NASAL | SPRAY, METERED | 931.6 MCG/SPRAY |
| NASAL | SPRAY, METERED | 1.9 % |
| NERVE BLOCK | INJECTABLE | NA |
| NERVE BLOCK | INJECTION | 7 MG/1ML |
| NERVE BLOCK | INJECTION | 0.9 % |
| NERVE BLOCK | SOLUTION, INJECTION | 0.9 % |
| OPHTHALMIC | DROPS | 0.65 % |
| OPHTHALMIC | GEL | 0.9 % |
| OPHTHALMIC | POWDER, FOR SOLUTION | 0.9 % |
| OPHTHALMIC | POWDER, FOR SUSPENSION | NA |
| OPHTHALMIC | SOLUTION | 8 mg/1mL |
| OPHTHALMIC | SOLUTION | 4 % |
| OPHTHALMIC | SOLUTION | 0.05 %W/V |
| OPHTHALMIC | SOLUTION, DROPS | 45 MG/5ML |
| OPHTHALMIC | SOLUTION, DROPS | 8 mg/1mL |
| OPHTHALMIC | SOLUTION, DROPS | 0.9 % |
| OPHTHALMIC | SOLUTION/ DROPS | 8.3 MG/1ML |
| OPHTHALMIC | SOLUTION/DROPS | 0.82 % |
| OPHTHALMIC | SUSPENSION | 0.85 % |
| OPHTHALMIC | SUSPENSION, DROPS | 0.68 % |
| ORAL | CAPSULE | 6 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 20.72 MG |
| ORAL | DROPS | NA |
| ORAL | GRANULE, FOR SUSPENSION | 13.5 MG |
| ORAL | POWDER, FOR ORAL SOLUTION | 25.27 MG |
| ORAL | POWDER, FOR ORAL SUSPENSION | 5 MG/5ML |
| ORAL | POWDER, FOR SOLUTION | NA |
| ORAL | POWDER, FOR SUSPENSION | 12.5 MG/5ML |
| ORAL | SOLUTION | 0.9 % |
| ORAL | SOLUTION, ELIXIR | 2 MG/5ML |
| ORAL | SOLUTION, FOR INHALATION | 27 MG |
| ORAL | SOLUTION, SYRUP | 0.4 MG/1ML |
| ORAL | SUSPENSION | 20 MG/1ML |
| ORAL | SUSPENSION, FOR INHALATION | 17 MG/2ML |
| ORAL | SYRUP | 3 MG/1ML |
| ORAL | TABLET | 150 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 7.5 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 36 MG |
| ORAL | TABLET, DELAYED ACTION | 24 MG |
| ORAL | TABLET, DELAYED RELEASE | 30 MG |
| ORAL | TABLET, EXTENDED RELEASE | 335.1 MG |
| ORAL | TABLET, FILM COATED | 100 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 10 MG |
| ORAL | TABLET, SUSTAINED ACTION | 143.26 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | 46.8 MG |
| OTIC | SUSPENSION | 0.53 % |
| PARENTERAL | INJECTABLE | 0.9 % |
| PARENTERAL | INJECTION | 24 % |
| PARENTERAL | LIQUID, WATER, STERILE, FOR INJECTION | 0.8 % |
| PERIDURAL | INJECTION | 0.81 % |
| PERINEURAL | INJECTION | 8.6 mg/1mL |
| PERINEURAL | INJECTION | 0.7 % |
| PHOTOPHERESIS | SOLUTION | 0.8 % |
| RECTAL | ENEMA | 0.7 % |
| RECTAL | SOLUTION | NA |
| RECTAL | SUPPOSITORY | 52.5 MG |
| RESPIRATORY (INHALATION) | INHALANT | 0.86 % |
| RESPIRATORY (INHALATION) | SOLUTION | 0.9 %W/V |
| RESPIRATORY (INHALATION) | SOLUTION, AEROSOL, FOR INHALATION | 0.23 % |
| RESPIRATORY (INHALATION) | SOLUTION, FOR INHALATION | 0.9 %W/V |
| RESPIRATORY (INHALATION) | SUSPENSION, FOR INHALATION | 0.85 %W/V |
| RETROBULBAR | INJECTION | 0.86 % |
| SOFT TISSUE | INJECTABLE | 0.66 % |
| SOFT TISSUE | INJECTION | 0.85 % |
| SOFT TISSUE | INJECTION, SUSTAINED ACTION | 0.9 % |
| SOFT TISSUE | SUSPENSION, INJECTION | 1.5 mg/1mL |
| SOFT TISSUE | SUSPENSION, INJECTION | 0.22 % |
| SUBARACHNOID | SOLUTION, INJECTION | 0.9 % |
| SUBCUTANEOUS | IMPLANT | 77 MG |
| SUBCUTANEOUS | INJECTABLE | 0.89 % |
| SUBCUTANEOUS | INJECTION | 9 MG/1ML |
| SUBCUTANEOUS | INJECTION | 6.08 MG/0.8ML |
| SUBCUTANEOUS | INJECTION | 4.56 MG/0.6ML |
| SUBCUTANEOUS | INJECTION | 4.2 MG/0.5ML |
| SUBCUTANEOUS | INJECTION | 3.04 MG/0.4ML |
| SUBCUTANEOUS | INJECTION | 0.44 % |
| SUBCUTANEOUS | INJECTION, SOLUTION | 0.7 % |
| SUBCUTANEOUS | LIQUID | 0.15 % |
| SUBCUTANEOUS | SOLUTION | 9 mg/1mL |
| SUBCUTANEOUS | SOLUTION | 0.7 % |
| SUBCUTANEOUS | SOLUTION, INJECTION | 2.25 % |
| SUBCUTANEOUS | SUSPENSION, INJECTION | 1.23 % |
| SUBMUCOSAL | INJECTION | 0.16 % |
| SUBMUCOSAL | SOLUTION, INJECTION | 16 % |
| TOPICAL | EMULSION, CREAM | NA |
| TOPICAL | GEL | 0.18 %W/W |
| TOPICAL | JELLY | NA |
| TOPICAL | LOTION | 0.3 %W/V |
| TOPICAL | OINTMENT | NA |
| TOPICAL | OPHTHALMIC SUSPENSION DOSAGE FORM | 0.5 %W/V |
| TOPICAL | PATCH, CONTROLLED RELEASE | 3.1 MG |
| TOPICAL | SHAMPOO | 2.25 %W/W |
| TOPICAL | SOLUTION | 6.4 MG/ML |
| TOPICAL | SOLUTION | 0.9 %W/V |
| TOPICAL | SOLUTION, DROPS | 0.86 %W/V |
| TOPICAL | SOLUTION/DROPS | 0.82 %W/V |
| TOPICAL | SUSPENSION | 0.3 %W/W |
| TOPICAL | SUSPENSION, DROPS | 5.05 MG/ML |
| TRANSDERMAL | DRUG DELIVERY SYSTEM | 0.6 MG |